Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2026-02-19 @ 5:26 PM
Study NCT ID:
NCT01430403
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2011-09-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Asthma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | persistent allergic asthma | View |
| None | asthma exacerbations reduction | View |
| None | Xolair® (omalizumab) | View |
| None | Flovent® Diskus® (fluticasone) | View |
| None | placebo | View |
| None | inhaled corticosteroid therapy | View |
| None | anti-immunoglobulin E therapy | View |
| None | anti-IgE therapy | View |